Works matching IS 03407004 AND DT 2003 AND VI 52

Results: 97

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 3, p. 155, doi. 10.1007/s00262-002-0360-9

By:

Iwashita, Yukio;
Tahara, Kouichirou;
Goto, Shigeru;
Sasaki, Atsushi;
Kai, Seiichiro;
Seike, Masataka;
Chen, Chao-Long;
Kawano, Katsunori;
Kitano, Seigo

Publication type:

Article

Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 739, doi. 10.1007/s00262-003-0405-8

By:

Parviz, Maryam;
Chin, Cynthia S.;
Graham, Laura J.;
Miller, Catriona;
Lee, Catherine;
George, Kimberly;
Bear, Harry D.

Publication type:

Article

IL-12: a promising adjuvant for cancer vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 3, p. 133, doi. 10.1007/s00262-002-0356-5

By:

Portielje, Johanna E.A.;
Gratama, Jan Willem;
van Ojik, Heidi H.;
Stoter, Gerrit;
Kruit, Wim H.J.

Publication type:

Article

Amifostine protects lymphocytes during radiotherapy and stimulates expansion of the CD95/Fas and CD31 expressing T-cells, in breast cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 127, doi. 10.1007/s00262-002-0342-y

By:

Koukourakis, Michael I.;
Ktenidou-Kartali, Sophia;
Bourikas, George;
Kartalis, George;
Tsatalas, Costas

Publication type:

Article

Naturally occurring B-cell responses to breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 715, doi. 10.1007/s00262-003-0409-4

By:

Coronella-Wood, Julia A.;
Hersh, Evan M.

Publication type:

Article

Tumor mRNA–loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 632, doi. 10.1007/s00262-003-0408-5

By:

Kobayashi, Tsutomu;
Yamanaka, Ryuya;
Homma, Junpei;
Tsuchiya, Naoto;
Yajima, Naoki;
Yoshida, Seiichi;
Tanaka, Ryuichi

Publication type:

Article

Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradication.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 751, doi. 10.1007/s00262-003-0410-y

By:

Lustgarten, Joseph

Publication type:

Article

Identification of new MHC-restriction elements for presentation of the p210BCR-ABL fusion region to human cytotoxic T lymphocytes.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 761, doi. 10.1007/s00262-003-0415-6

By:

Ji-Yao Sun;
Senitzer, David;
Forman, Stephen J.;
Chatterjee, Saswati;
Wong, Jr., K. K.

Publication type:

Article

Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 771, doi. 10.1007/s00262-003-0420-9

By:

Sotiropoulou, Panagiota A.;
Perez, Sonia A.;
Voelter, Volfgang;
Echner, Hartmut;
Missitzis, Ioannis;
Tsavaris, Nick B.;
Papamichail, Michael;
Baxevanis, Constantin N.

Publication type:

Article

Heparan sulphate epitope–expression is associated with the inflammatory response in metastatic malignant melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 780, doi. 10.1007/s00262-003-0421-8

By:

Bernsen, Monique R.;
Smetsers, Toon F. C. M.;
van de Westerlo, Els;
Ruiter, Dirk J.;
Håkansson, Leif;
Gustafsson, Bertil;
van Kuppevelt, Toin H.;
Krysander, Lennart;
Rettrup, Björn;
Håkansson, Annika

Publication type:

Article

l-Ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8–independent pathway.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 693, doi. 10.1007/s00262-003-0407-6

By:

Jae Seung Kang;
Daeho Cho;
Young-In Kim;
Eunsil Hahm;
Yoolhee Yang;
Daejin Kim;
Daeyoung Hur;
Hyunjeong Park;
Saic Bang;
Young Il Hwang;
Wang Jae Lee

Publication type:

Article

Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 699, doi. 10.1007/s00262-003-0412-9

By:

Bouet-Toussaint, Françoise;
Patard, Jean-Jacques;
Gervais, Alban;
Genetet, Noëlle;
de la Pintière, Cécile Thomas;
Rioux-Leclercq, Nathalie;
Toutirais, Olivier;
Thirouard, Anne-Sophie;
Ramée, Marie-Paule;
Catros-Quemener, Véronique

Publication type:

Article

Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 708, doi. 10.1007/s00262-003-0413-8

By:

Valeri, A. P.;
Pérez-Blas, M.;
Gutiérrez, A.;
López-Santalla, M.;
Aguilera, N.;
Rodríguez-Juan, C.;
Sala-Silveira, L.;
Martín, J.;
Lasa, I.;
Mugüerza, J. M.;
López, A.;
García-Sancho, L.;
Granell, J.;
Martín-Villa, J. M.

Publication type:

Article

Cellular immunity for cancer chemoimmunotherapy—an overview.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 661, doi. 10.1007/s00262-003-0423-6

By:

Mihich, Enrico

Publication type:

Article

Modulation of costimulation to enhance tumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 663, doi. 10.1007/s00262-003-0424-5

By:

Vesosky, Bridget;
Hurwitz, Arthur A.

Publication type:

Article

Tumor microvasculature as a barrier to antitumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 670, doi. 10.1007/s00262-003-0425-4

By:

Qing Chen;
Wan-Chao Wang;
Evans, Sharon S.

Publication type:

Article

On combining antineoplastic drugs with tumor vaccines.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 680, doi. 10.1007/s00262-003-0426-3

By:

Terando, Alicia;
Mulé, James J.

Publication type:

Article

Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 599, doi. 10.1007/s00262-003-0395-6

By:

Tsukishiro, Takashi;
Donnenberg, Albert D.;
Whiteside, Theresa L.

Publication type:

Article

Combinations of anticancer drugs and immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 686, doi. 10.1007/s00262-003-0427-2

By:

Mitchell, Malcolm S.

Publication type:

Article

The effects of αGalCer-induced TCRVα24 Vβ11+ natural killer T cells on NK cell cytotoxicity in umbilical cord blood.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 625, doi. 10.1007/s00262-003-0398-3

By:

Ueda, Yoko;
Hagihara, Masao;
Gansuvd, Balgansuren;
Ying Yu;
Masui, Aya;
Okamoto, Ayako;
Higuchi, Ayako;
Tazume, Kei;
Kato, Syunichi;
Hotta, Tomomitsu

Publication type:

Article

A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 608, doi. 10.1007/s00262-003-0399-2

By:

Ragupathi, Govind;
Koide, Fusataka;
Sathyan, Natarajan;
Kagan, Ella;
Spassova, Maria;
Bornmann, William;
Gregor, Polly;
Reis, Celso A.;
Clausen, Henrik;
Danishefsky, Samuel J.;
Livingston, Philip O.

Publication type:

Article

Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 643, doi. 10.1007/s00262-003-0400-0

By:

Sanz, Laura;
Feijóo, Mónica;
Blanco, Belén;
Serrano, Antonio;
Álvarez-Vallina, Luis

Publication type:

Article

Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 638, doi. 10.1007/s00262-003-0402-y

By:

Durrant, L. G.;
Chapman, M. A.;
Buckley, D. J.;
Spendlove, I.;
Robins, R. A.;
Armitage, N. C.

Publication type:

Article

Tumor immunotherapy by converting tumor cells to MHC class II–positive, Ii protein–negative phenotype.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 592, doi. 10.1007/s00262-003-0404-9

By:

Xueqing Lu;
Kallinteris, Nikoletta L.;
Jizhi Li;
Shuzhen Wu;
Yu Li;
Zhong Jiang;
Hillman, Gilda G.;
Gulfo, Joseph V.;
Humphreys, Robert E.;
Minzhen Xu

Publication type:

Article

Lymphocyte subsets and Th1/Th2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 617, doi. 10.1007/s00262-003-0406-7

By:

van Sandick, Johanna W.;
Boermeester, Marja A.;
Gisbertz, Suzanne S.;
ten Berge, Ineke J. M.;
Out, Theo A.;
van der Pouw Kraan, Tineke C. T. M.;
van Lanschot, J. Jan B.

Publication type:

Article

Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 67, doi. 10.1007/s00262-002-0338-7

By:

Vegh, Zsuzsa;
Mazumder, Amitabha

Publication type:

Article

Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 2, p. 80, doi. 10.1007/s00262-002-0335-x

By:

Ito, Akira;
Shinkai, Masashige;
Honda, Hiroyuki;
Yoshikawa, Kazuhiro;
Saga, Shinsuke;
Wakabayashi, Toshihiko;
Yoshida, Jun;
Kobayashi, Takeshi

Publication type:

Article

Optimizing dendritic cell–based anticancer immunotherapy: maturation state does have clinical impact.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 583, doi. 10.1007/s00262-003-0414-7

By:

McIlroy, Dorian;
Gregoire, Marc

Publication type:

Article

Development of Therapeutic Cancer Vaccines Conference, 27–29 April 2003.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 648, doi. 10.1007/s00262-003-0422-7

By:

Marshall, Margaret

Publication type:

Article

Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 655, doi. 10.1007/s00262-003-0438-z

By:

Mitchell, Malcolm S.;
Kast, W. Martin

Publication type:

Article

NK cells in allogeneic bone marrow transplantation.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 525, doi. 10.1007/s00262-003-0378-7

By:

Voutsadakis, Ioannis A.

Publication type:

Article

Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 535, doi. 10.1007/s00262-003-0383-x

By:

Ciavarra, Richard P.;
Brown, Roy R.;
Holterman, Daniel A.;
Garrett, Marianne;
Glass II, William F.;
Wright, George L.;
Schellhammer, Paul F.;
Somers, Kenneth D.

Publication type:

Article

CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 546, doi. 10.1007/s00262-003-0392-9

By:

Shingu, Kiyoshi;
Helfritz, Andreas;
Zielinska-Skowronek, Margot;
Meyer-Olson, Dirk;
Jacobs, Roland;
Schmidt, Reinhold E.;
Mentlein, Rolf;
Pabst, Reinhard;
von Hörsten, Stephan

Publication type:

Article

Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 555, doi. 10.1007/s00262-003-0393-8

By:

Ebina, Takusaburo;
Ogama, Naoko;
Shimanuki, Hiroko;
Kubota, Tomoka;
Isono, Noriko

Publication type:

Article

Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 561, doi. 10.1007/s00262-003-0394-7

By:

Kuroki, Hideo;
Morisaki, Takashi;
Matsumoto, Kotaro;
Onishi, Hideya;
Baba, Eishi;
Tanaka, Masao;
Katano, Mitsuo

Publication type:

Article

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 576, doi. 10.1007/s00262-003-0396-5

By:

Colnot, David R.;
Roos, Jan C.;
de Bree, Remco;
Wilhelm, Abraham J.;
Kummer, J. Alain;
Hanft, Gertraud;
Heider, Karl-Heinz;
Stehle, Gerd;
Snow, Gordon B.;
van Dongen, Guus A. M. S.

Publication type:

Article

Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 569, doi. 10.1007/s00262-003-0401-z

By:

Otten, Henderikus G.;
de Gast, Gijsbert C.;
Vooijs, Wim C.;
van der Gouw, Alexander P.;
de Boer, Mark;
Ossevoort, Mirjam A.;
Jonker, Margreet

Publication type:

Article

In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the γ-chain from Fc(ε) RI.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 513, doi. 10.1007/s00262-002-0371-6

By:

Mamalaki, Avgi;
Gritzapis, Angelos D.;
Kretsovali, Androniki;
Belimezi, Maria;
Papamatheakis, Joseph;
Perez, Sonia A.;
Papamichail, Michael;
Baxevanis, Constantin N.

Publication type:

Article

Targeted cytotoxic effect of anti-JL1 immunotoxin against a human leukemic cell line and its clinical implications.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 506, doi. 10.1007/s00262-003-0374-y

By:

Young Kee Shin;
Yoon La Choi;
Eun Young Choi;
Min Kyung Kim;
Myeong-Cherl Kook;
Junho Chung;
Yang-Kyu Choi;
Heung Sik Kim;
Hyung Geun Song;
Seong Hoe Park

Publication type:

Article

Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 497, doi. 10.1007/s00262-003-0377-8

By:

Chakraborty, Nitya G.;
Stevens, Robert L.;
Mehrotra, Shikhar;
Laska, Elizabeth;
Taxel, Pamela;
Sporn, Jonathan R.;
Schauer, Peter;
Albertsen, Peter C.

Publication type:

Article

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 481, doi. 10.1007/s00262-003-0384-9

By:

Watanabe, Etsuya;
Matsuyama, Hideyasu;
Matsuda, Kenji;
Ohmi, Chietaka;
Tei, Yasuhide;
Yoshihiro, Satoru;
Ohmoto, Yasukazu;
Naito, Katsusuke

Publication type:

Article

Therapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 487, doi. 10.1007/s00262-003-0385-8

By:

Moiseeva, Ekaterina V.;
Merkulova, Irina B.;
Bijleveld, Caspaar;
Koten, Jan-Willem;
Miroshnikov, Anatoly I.;
Den Otter, Willem

Publication type:

Article

Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 473, doi. 10.1007/s00262-003-0387-6

By:

Thamm, Douglas H.;
Kurzman, Ilene D.;
Macewen, E. Gregory;
Feinmehl, Rhonda;
Towell, Todd L.;
Longhofer, Susan L.;
Johnson, Christine M.;
Geoly, Frank J.;
Stinchcomb, Dan T.

Publication type:

Article

Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.

Published in:

2003

By:

Westers, Theresia M.;
Stam, Anita G. M.;
Scheper, Rik J.;
Regelink, Johanna C.;
Nieuwint, Aggie W. M.;
Schuurhuis, Gerrit Jan;
van de Loosdrecht, Arjan A.;
Ossenkoppele, Gert J.

Publication type:

Erratum

Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulation.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 445, doi. 10.1007/s00262-002-0368-1

By:

Spisek, Radek;
Bougras, Gwenola;
Ebstein, Frederic;
Masse, Delphine;
Meflah, Khaled;
McIlroy, Dorian;
Gregoire, Marc

Publication type:

Article

Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 413, doi. 10.1007/s00262-003-0382-y

By:

Zhou, Yaling;
McEarchern, Julie A.;
Howard, Edward;
Pestano, Gary;
Salgaller, Michael L.;
Bosch, Marnix L.

Publication type:

Article

Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 429, doi. 10.1007/s00262-003-0386-7

By:

Thurmond, Linda M.;
Stimmel, Julie B.;
Ingram, Adrienne C.;
Ryan, Christian H.;
Murray, Doris M.;
Eberwein, Derek J.;
Witherspoon, Sam M.;
Knick, Vincent C.

Publication type:

Article

Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 423, doi. 10.1007/s00262-003-0388-5

By:

Diederichsen, Axel C. P.;
Hjelmborg, J. v. B.;
Christensen, Per B.;
Zeuthen, Jesper;
Fenger, Claus

Publication type:

Article

Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 455, doi. 10.1007/s00262-003-0389-4

By:

Houtenbos, Ilse;
Westers, Theresia M.;
Stam, Anita G. M.;
de Gruijl, Tanja D.;
Scheper, Rik J.;
Ossenkoppele, Gert J.;
van de Loosdrecht, Arjan A.

Publication type:

Article

Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 438, doi. 10.1007/s00262-003-0390-y

By:

Lesimple, Thierry;
Moisan, Annick;
Carsin, André;
Ollivier, Isabelle;
Mousseau, Mireille;
Meunier, Bernard;
Leberre, Claudine;
Collet, Brigitte;
Quillien, Véronique;
Drenou, Bernard;
Lefeuvre-Plesse, Claudia;
Chevrant-Breton, Jacqueline;
Toujas, Louis

Publication type:

Article